CIK 0001479419
- Non-accelerated filer
- Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270604595
- Phone
- +1 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-05 | PERRY GREGORY D Director | Grant or award · Stock Option (right to buy) | +21,000 | 21,000 | ||
| 2019-06-05 | Paull Robert Bradley Director | Grant or award · Stock Option (right to buy) | +21,000 | 21,000 | ||
| 2019-06-05 | Grunberg Gregory Director | Grant or award · Stock Option (right to buy) | +21,000 | 21,000 | ||
| 2019-06-05 | KOVEN ANDREW I Director | Grant or award · Stock Option (right to buy) | +21,000 | 21,000 | ||
| 2019-06-05 | Shah Rajeev M. Director | Grant or award · Stock Option (right to buy) | +21,000 | 21,000 | ||
| 2019-05-30 | Rosen Howard B Director | Purchase | +5,000 | $5.42 | $27K | 8,240 |
| 2019-01-02 | Iwicki Mark T Chief Executive Officer | Grant or award · Stock Option (right to buy) | +460,000 | 460,000 | ||
| 2019-01-02 | Brazzell Romulus K Chief Medical Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2019-01-02 | Bazemore Todd Chief Operating Officer | Grant or award · Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2019-01-02 | Chen Hongming Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2019-01-02 | Trachtenberg Eric | Grant or award · Stock Option (right to buy) | +165,000 | 165,000 | ||
| 2019-01-02 | Reumuth Mary Chief Financial Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2018-10-05 | Grunberg Gregory Director | Purchase | +606,060 | $8.25 | $5.0M | 2,877,006 |
| 2018-10-03 | Shah Rajeev M. Director | Purchase | +2,424,242 | $8.25 | $20.0M | 4,537,478 |
| 2018-10-03 | RA CAPITAL MANAGEMENT, LLC Director | Purchase | +2,424,242 | $8.25 | $20.0M | 4,537,478 |
| 2018-06-12 | Shah Rajeev M. Director | Grant or award · Stock Option (right to buy) | +12,960 | 12,960 | ||
| 2018-06-11 | Paull Robert Bradley Director | Other acquisition | +477 | 1,074 | ||
| 2018-05-18 | Paull Robert Bradley Director | Other acquisition | +597 | 597 |
Page 19 of 19 · 378 trades